PGI21 a Comparison of the Cost-Effectiveness of Fidaxomicin, Metronidazole, and Vancomycin, in the Treatment of Clostridium Difficile-Associated Disease

Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.748
https://www.valueinhealthjournal.com/article/S1098-3015(12)00813-3/fulltext
Title : PGI21 a Comparison of the Cost-Effectiveness of Fidaxomicin, Metronidazole, and Vancomycin, in the Treatment of Clostridium Difficile-Associated Disease
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00813-3&doi=10.1016/j.jval.2012.03.748
First page : A138
Section Title : Gastrointestinal Disorders
Open access? : No
Section Order : 222
Categories :
Tags :
Regions :
ViH Article Tags :